Design Therapeutics (DSGN) PEG Ratio
Market Cap: $230.46M
Avg Volume: 146.86K
Industry: Biotechnology
Sector: Healthcare
PEG Ratio Summary
- Design Therapeutics's trailing twelve month (TTM) PEG ratio is 1.31.
- Design Therapeutics's annual PEG ratio as of today is 0.27.
- Design Therapeutics's quarterly PEG ratio is -1.47.
What is the PEG Ratio?
The PEG ratio (Price/Earnings to Growth ratio) is a valuation metric for determining the relative trade-off between the price of a stock, the earnings generated per share (EPS), and the company's expected growth. A lower PEG ratio suggests that a stock may be undervalued given its earnings performance and growth potential.
How is the PEG Ratio calculated?
The PEG ratio is calculated by dividing the P/E ratio by the annual EPS growth. The formula is:
PEG Ratio = (P/E Ratio) / (EPS Growth Rate)
This helps investors to determine a stock's value while considering the company's earnings growth.
Related Metrics
Other important metrics to assess Design Therapeutics's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: -7.04
- Quarterly: -6.39
- TTM: -4.63
- P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
- Annual: 0.00
- Quarterly: 0.00
- TTM: 0.00
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: 1.44
- Quarterly: 1.44
- TTM: 0.95
- P/CF Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: -8.10
- Quarterly: -35.41
- TTM: -5.33
These metrics provide insights into Design Therapeutics's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
TTM PEG Ratio
1.31
Annual PEG Ratio
0.27
Quarterly PEG Ratio
-1.47
Design Therapeutics Historical PEG Ratio
Historical P/E Ratio
Historical P/S Ratio
Historical P/B Ratio
Historical P/CF Ratio
Design Therapeutics Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | PEG Ratio | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|---|
| 2024 | 0.27 | -7.04 | 0.00 | 1.44 | -8.10 |
| 2023 | -0.17 | -2.22 | 0.00 | 0.53 | -2.53 |
| 2022 | -0.27 | -9.75 | 0.00 | 1.75 | -11.14 |
| 2021 | -0.18 | -27.68 | 0.00 | 2.57 | -33.48 |
| 2020 | -0.46 | -136.25 | 4991650.88 | -99.70 | -130.13 |
| 2019 | 0.00 | -551.11 | 1352653.60 | -309.75 | -8115.92 |
Related Metrics
Explore detailed financial metrics and analysis for DSGN.